Spesolimab
ATC L04AC22 · 8 markets · 20 records
US 6 records · 4 strengths
AU 4 records · 4 strengths
- 150 mginjectionSPEVIGO spesolimab (rch) 150 mg in 1 mL solution for injection pre-filled syringe
- 300 mginjectionSPEVIGO spesolimab (rch) 150 mg in 1 mL solution for injection pre-filled syringe
- 450 mginjectionSPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial
Records without a stated strength · 1 SPEVIGO
CA 3 records · 3 strengths
TW 2 records · 2 strengths
- 150 mginjectionSpevigo solution for injection 150mg/ml希蓓麗活皮下注射液
Records without a stated strength · 1 Spevigo solution for infusion、希蓓麗活靜脈輸注液
HK 2 records · 1 strengths
Records without a stated strength · 1 SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML、SPEVIGO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/1ML
GB 1 records · 1 strengths
- 450 mg/7.5 mLinjectionSpevigo 450mg/7.5ml concentrate for solution for infusion vials
SG 1 records · 1 strengths
- 450 mg/7.5 mLinjectionSPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 SPEVIGO
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.